HLA-DRB1*04 gene polymorphisms and expressions profiles of interleukin-18 and interleukin-18 binding protein following in vitro stimulation in human peripheral blood mononuclear cells of healthy individuals and patients with rheumatoid arthritis

Life Sciences

Volumn 80, Issue 20, 2007, Pages 1887-1896

  Sivalingam, S P ^a   Thumboo, J ^a,b   Vasoo, S ^a   Fong, K Y ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Cytokines; Inflammation; Macrophages; Monocytes

Indexed keywords

CYTOKINE; HLA DR ANTIGEN; INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN; MESSENGER RNA; MITOGENIC AGENT; HLA-DRB1 ANTIGEN; INTERLEUKIN 18 RECEPTOR; INTERLEUKIN-18 BINDING PROTEIN; LIPOPOLYSACCHARIDE; PHYTOHEMAGGLUTININ; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL STIMULATION; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEFORMITY; DISABILITY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION PROFILING; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SUPERNATANT; BLOOD; COMPARATIVE STUDY; DRUG EFFECT; GENETICS; METABOLISM; MONONUCLEAR CELL; PHYSIOLOGY;

ARTHRITIS, RHEUMATOID; GENE EXPRESSION PROFILING; HLA-DR ANTIGENS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-18; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; PHYTOHEMAGGLUTININS; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN-18; RNA, MESSENGER;

EID: 34147097011     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.02.020     Document Type: Article

References (51)

1. Abdalla A.O., Kiaii S., Hansson L., Rossmann E.D., Jeddi-Tehrani M., Shokri F., Osterborg A., Mellstedt H., and Rabbani H. Kinetics of cytokine gene expression in human CD4+ and CD8+ T-lymphocyte subsets using quantitative real-time PCR. Scandinavian Journal of Immunology 58 6 (2003) 601-606
2. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., Healey L.A., Kaplan S.R., Liang M.H., Luthra H.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 31 (1988) 315-324
3. Auger I., and Roudier J. Influence of the QKRAA/QRRAA/RRRAA motifs of the third hypervariable region of HLA-DRB1 in the development of rheumatoid arthritis. Journal of Rheumatology 24 (1997) 227-228
4. Barth S., Kleinhappl B., Gutschi A., Jelovcan S., and Marth E. In vitro cytokine mRNA expression in normal human peripheral blood mononuclear cells. Inflammation Research 49 6 (2000) 266-274
5. Bessis N.M., and Boissier C. Novel pro-inflammatory interleukins: potential therapeutic targets in rheumatoid arthritis. Joint Bone Spine 68 6 (2001) 477-481
6. Bresnihan B., Roux-Lombard P., Murphy E., Kane D., FitzGerald O., and Dayer J.M. Serum interleukin 18 and interleukin 18 binding protein in rheumatoid arthritis. Annals of the Rheumatic Diseases 61 8 (2002) 726-729
7. Brown J.H., Jardetzky T.S., Gorga J.C., Stern L.J., Urban R.G., Strominger J.L., and Wiley D.C. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364 6432 (1993) 33-39
8. Dayer J.M. Interleukin-18, rheumatoid arthritis, and tissue destruction. Journal of Clinical Investigation 104 (1999) 1337-1339
9. Dinarello C.A. IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. Journal of Allergy and Clinical Immunology 103 1 Pt 1 (1999) 11-24
10. Dinarello C.A. Interleukin-18, a pro-inflammatory cytokine. European Cytokine Network 11 (2000) 483-486
11. Falcone M., and Sarvetnick N. Cytokines that regulate autoimmune responses. Current Opinion in Immunology 11 6 (1999) 670-676
12. Fan J., Marshall J.C., Jimenez M., Shek P.N., Zagorski J., and Rotstein O.D. Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide. Journal of Immunology 161 1 (1998) 440-447
13. Feldmann M., Brennan F.M., and Maini R.N. Rheumatoid arthritis. Cell 85 3 (1996) 307-310
14. Feldmann M., Brennan F.M., and Maini R.N. Role of cytokines in rheumatoid arthritis. Annual Review of Immunology 14 (1996) 397-440
15. Feldmann M., Bondeson J., Brennan F.M., Foxwell B.M., and Maini R.N. The rationale for the current boom in anti-TNFalpha treatment. Is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNFalpha and minimise hazards?. Annals of the Rheumatic Diseases 58 Suppl 1 (1999) I27-I31
16. Gao X., Gazit E., Livneh A., and Stastny P. Rheumatoid arthritis in Israeli Jews: shared sequences in the third hypervariable region of DRB1 alleles are associated with susceptibility. Journal of Rheumatology 18 (1991) 801-803
17. Gauchat J.F., Gauchat D., De Weck A.L., and Stadler B.M. Cytokine mRNA levels in antigen-stimulated peripheral blood mononuclear cells. European Journal of Immunology 19 6 (1989) 1079-1085
18. Giulietti A., Overbergh L., Valckx D., Decallonne B., Bouillon R., and Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25 4 (2001) 386-401
19. Gracie J.A., Forsey R.J., Chan W.L., Gilmour A., Leung B.P., Greer M.R., Kennedy K., Carter R., Wei X.Q., Xu D., Field M., Foulis A., Liew F.Y., and McInnes I.B. A proinflammatory role for IL-18 in rheumatoid arthritis. Journal of Clinical Investigation 104 10 (1999) 1393-1401
20. Gregersen P.K., Silver J., and Winchester R.J. The shared epitope hypothesis: an approach to understanding the molecular genetics of rheumatoid arthritis susceptibility. Arthritis and Rheumatism 30 (1987) 1205-1213
21. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., and Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. Journal of Immunology 162 (1999) 3749-3752
22. Joosten L.A., Radstake T.R., Lubberts E., van den Bersselaar L.A., van Riel P.L., van Lent P.L., Barrera P., and van den Berg W.B. Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis. Arthritis and Rheumatism 48 2 (2003) 339-347
23. Kawashima M., Novick D., Rubinstein M., and Miossec P. Regulation of interleukin-18 binding protein production by blood and synovial cells from patients with rheumatoid arthritis. Arthritis and Rheumatism 50 6 (2004) 1800-1805
24. - ΔΔCT method. Methods 25 (2001) 402-408
25. *0405 in Korean patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 54 12 (1995) 988-990
26. Kim S.H., Eisenstein M., Reznikov L., Fantuzzi G., Novick D., Rubinstein M., and Dinarello C.A. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proceedings of the National Academy of Sciences of the United States of America 97 (2000) 1190-1195
27. Kong K.F., Yeap S.S., Chow S.K., and Phipps M.E. HLA-DRB1 genes and susceptibility to rheumatoid arthritis in three ethnic groups from Malaysia. Autoimmunity 35 4 (2002) 235-239
28. Larsen B.A., Alderdice C.A., Hawkins D., Martin J.R., Mitchell M.M., and Sheridan D.P. Protective HLA-DR phenotypes in rheumatoid arthritis. Journal of Rheumatology 16 4 (1989) 455-458
29. Lee Y.H., Kim H.J., Rho Y.H., Choi S.J., Ji J.D., and Song G.G. Interleukin-1 receptor antagonist gene polymorphism and rheumatoid arthritis. Rheumatology International 24 3 (2004) 133-136
30. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research 16 (1988) 1215
31. Nakamura K., Okamura H., Wada M., Nagata K., and Tamura T. Endotoxin-induced serum factor that stimulates gamma interferon production. Infection and immunity 57 2 (1989) 590-595
32. Nepom G.T. Major histocompatibility complex-directed susceptibility to rheumatoid arthritis. Advances in Immunology 68 (1998) 315-332
33. Novick D., Kim S.H., Fantuzzi G., Reznikov L.L., Dinarello C.A., and Rubinstein M. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10 (1999) 127-136
34. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K., et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378 6552 (1995) 88-91
35. O'Neill L. The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defence. Biochemical Society Transactions 28 5 (2000) 557-563
36. O'Neill L. How Toll-like receptors signal: what we know and what we don't know. Current Opinion in Immunology 17 (2005) 1-7
37. Ota M., and Inoko H. Modified PCR-RFLP method for HLA-DPB1 and DQA1 genotyping. Tissue Antigens 38 (1991) 60
38. Pawlik A., Kurzawski M., Czerny B., Gawronska-Szklarz B., Drozdzik M., and Herczynska M. Interleukin-18 promoter polymorphism in patients with rheumatoid arthritis. Tissue Antigens 67 5 (2006) 415-418
39. Prevoo M.L., van't Hof M.A., Kuper H.H., van Leeuwen M.A., van de Putte L.B., and van Riel P.L. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis and Rheumatism 38 (1995) 44-48
40. Rueda B., Gonzalez-Gay M.A., Mataran L., Lopez-Nevot M.A., and Martin J. Interleukin-18-promoter polymorphisms are not relevant in rheumatoid arthritis. Tissue Antigens 65 6 (2005) 544-548
41. Ruiz-Morales J.A., Vargas-Alarcon G., Flores-Villanueva P.O., Villarreal-Garza C., Hernandez-Pacheco G., Yamamoto-Furusho J.K., Rodriguez-Perez J.M., Perez-Hernandez N., Rull M., Cardiel M.H., and Granados J. HLA-DRB1 alleles encoding the "shared epitope" are associated with susceptibility to developing rheumatoid arthritis whereas HLA-DRB1 alleles encoding an aspartic acid at position 70 of the beta-chain are protective in Mexican mestizos. Human Immunology 65 (2004) 262-269
42. Seki E., Tsutsui H., Nakano H., Tsuji N., Hoshino K., Adachi O., Adachi K., Futatsugi S., Kuida K., Takeuchi O., Okamura H., Fujimoto J., Akira S., and Nakanishi K. Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1beta. Journal of Immunology 166 4 (2001) 2651-2657
43. Sims J.E. IL-1 and IL-18 receptors and their extended family. Current Opinion in Immunology 14 (2001) 117
44. Sivalingam S.P., Yoon K.H., Koh D.R., and Fong K.Y. Single-nucleotide polymorphisms of the interleukin-18 gene promoter region in rheumatoid arthritis patients: protective effect of AA genotype. Tissue Antigens 62 6 (2003) 498-504
45. Ushio S., Namba M., Okura T., Hattori K., Nukada Y., Akita K., Tanabe F., Konishi K., Micallef M., Fujii M., Torigoe K., Tanimoto T., Fukuda S., Ikeda M., Okamura H., and Kurimoto M. Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. Journal of Immunology 156 11 (1996) 4274-4279
46. Wakitani S., Murata N., Toda Y., Ogawa R., Kaneshige T., Nishimura Y., and Ochi T. The relationship between HLA-DRB1 alleles and disease subsets of rheumatoid arthritis in Japanese. British Journal of Rheumatology 36 (1997) 630-636
47. *0405 in Japanese patients. Scandinavian Journal of Rheumatology 27 2 (1998) 146-148
48. Weyand C.M., Hicok K.C., Conn D.L., and Goronzy J.J. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Annals of Internal Medicine 117 10 (1992) 801-806
49. Wordsworth B.P., Lanchbury J.S., Sakkas L.I., Welsh K.I., Panayi G.S., and Bell J.I. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proceedings of the National Academy of Sciences of the United States of America 86 (1989) 10049-10053
50. Yamamura M., Kawashima M., Taniai M., et al. Interferon-γ-inducing activity of interleukin-18 in the joint with rheumatoid arthritis. Arthritis and Rheumatism 44 (2001) 275-285
51. Yen J.H., Chen J.R., Tsai W.J., Tsai J.J., and Liu H.W. HLA-DRB1 genotyping in patients with rheumatoid arthritis in Taiwan. Journal of Rheumatology 22 8 (1995) 1450-1454